Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast CancerJessica L. Christenson, Jennifer K. Richer|Molecular Cancer Therapeutics|2021Cited by 51
t-Darpp overexpression in HER2-positive breast cancer confers a survival advantage in lapatinibJessica L. Christenson, Susan E. Kane|Oncotarget|2015Cited by 22
Darpp-32 and t-Darpp are differentially expressed in normal and malignant mouse mammary tissueJessica L. Christenson, Susan E. Kane|Molecular Cancer|2014Cited by 17